0001652252-17-000006.txt : 20170307 0001652252-17-000006.hdr.sgml : 20170307 20170307155238 ACCESSION NUMBER: 0001652252-17-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170306 FILED AS OF DATE: 20170307 DATE AS OF CHANGE: 20170307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO RAD LABORATORIES INC CENTRAL INDEX KEY: 0000012208 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 941381833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 BUSINESS PHONE: 5107247000 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Magni Giovanni CENTRAL INDEX KEY: 0001292816 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07928 FILM NUMBER: 17671888 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-03-06 0000012208 BIO RAD LABORATORIES INC BIO, BIOB 0001292816 Magni Giovanni C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES CA 94547 0 1 0 0 EVP, Chief Strategy Officer Bio-Rad A Common Stock 2017-03-06 4 S 0 998 196.1637 D 12656 D Bio-Rad A Common Stock 2017-03-06 4 M 0 3500 75.32 A 16156 D Bio-Rad A Common Stock 2017-03-06 4 S 0 3500 195.8652 D 12656 D Non-Qualified Stock Option (right to buy) 75.32 2017-03-06 4 M 0 3500 0 D 2017-08-01 Bio-Rad A Common Stock 3500 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.15 to $196.25, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.11 to $196.40, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vested in five equal annual installments beginning August 1, 2008. Giovanni Magni 2017-03-07